Flisiak, Robert

Publishing since 1990 (Dinosaur)

Has published 89 publications in 21 years

Number of publications published per year by Flisiak, Robert. (Source : PubMed)

Distribution of publications types for Flisiak, Robert. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Jaroszewicz J, Serrano BC, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.  J. Hepatol.  2010;52;4  
•  Flisiak R, Parfieniuk A. Investigational drugs for hepatitis C.  Expert Opin Investig Drugs  2010;19;1  
•  Panasiuk A, Parfieniuk A, Zak J, Flisiak R. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.  Liver Int.  2009  
•  Lapinski TW, Parfieniuk A, Rogalska-Plonska M, Czajkowska J, Flisiak R. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.  Liver Int.  2009;29;8  
•  Dabrowska MM, Panasiuk A, Flisiak R. [HCV entry as a new therapeutic target in chronic hepatitis C]  Pol. Merkur. Lekarski  2009;27;158  
•  Dabrowska MM, Panasiuk A, Flisiak R. Signal transduction pathways in liver and the influence of hepatitis C virus infection on their activities.  World J. Gastroenterol.  2009;15;18  
•  Flisiak R, Feinman SV, Jablkowski M, Horban A, Kryczka W, Pawlowska M, Heathcote JE, Mazzella G, Vandelli C, Nicolas-Métral V, Grosgurin P, Liz JS, Scalfaro P, Porchet H, Crabbé R. The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.  Hepatology  2009;49;5  
•  Łapiński TW, Pawluczuk P, Flisiak R. [Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland]  Przegl Epidemiol  2009;63;4  
•  Lapiński TW, Kovalchuk O, Parfieniuk A, Flisiak R. [Prevalence, clinical and therapeutical implications of active CMV infection in patients with chronic hepatitis C]  Przegl Epidemiol  2009;63;2  
•  Lapiński TW, Rogalska-Płońska M, Czajkowska J, Flisiak R. [Influence of cryoglobulinaemia on renal function in patients with chronic HCV infection]  Przegl Epidemiol  2009;63;1  

[ See timeline ] [ See all publications ]